GT Biopharma, Inc.
GTBP
$0.42
-$0.01-1.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 277.29% | 72.39% | -60.61% | -43.47% | -75.88% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 104.50% | 201.60% | 279.03% | 5,694.44% | 156.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 613.98% | 682.80% | 817.20% | -- | -- |
| Total Current Assets | 276.07% | 91.54% | -36.07% | -23.13% | -73.11% |
|
|
|||||
| Total Current Assets | 276.07% | 91.54% | -36.07% | -23.13% | -73.11% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 276.07% | 91.54% | -36.07% | -23.13% | -73.18% |
|
|
|||||
| Total Accounts Payable | -89.37% | -80.59% | -70.56% | -19.98% | -25.93% |
| Total Accrued Expenses | 91.08% | -13.19% | -78.59% | -65.55% | 17.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -95.63% | -16.48% | 17.33% | -68.02% |
| Total Other Current Liabilities | -- | -95.63% | -16.48% | 17.33% | -68.02% |
| Total Current Liabilities | -33.59% | -60.71% | -71.66% | -38.63% | -20.91% |
|
|
|||||
| Total Current Liabilities | -33.59% | -60.71% | -71.66% | -38.63% | -20.91% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -33.59% | -60.71% | -71.66% | -38.63% | -20.91% |
|
|
|||||
| Common Stock & APIC | 5.67% | 5.21% | 1.48% | 0.99% | 0.78% |
| Retained Earnings | -4.43% | -4.12% | -1.35% | -1.38% | -1.71% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 872.58% | 446.26% | 43.08% | -48.07% | -118.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 195,600.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 195,600.00% | 0.00% |
|
|
|||||
| Total Common Equity | 872.58% | 446.26% | 43.08% | -48.07% | -118.47% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 195,600.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 873.47% | 446.53% | 43.06% | -12.55% | -118.45% |
|
|
|||||